Evidence map›Paper›PMID 32598982›Full record

ReviewNeuroscience and biobehavioral reviews2020

Advances in understanding mechanisms and therapeutic targets to treat comorbid depression and cardiovascular disease.

Brittany S Pope, Susan K Wood

Open access · greenAbstract readReview
In one paragraph

Review in Neuroscience and biobehavioral reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Brittany S PopeDepartment of Exercise Science, University of South Carolina Arnold School of Public Health, Columbia, SC, 20208, United States.
Susan K WoodDepartment of Pharmacology, Physiology, and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, 29209, United States; William Jennings Bryan Dorn Veterans Administration Medical Center, Columbia, SC, 29209, United States. Electronic address: Susan.Wood@uscmed.sc.edu.
University of South Carolina · USWm. Jennings Bryan Dorn VA Medical Center · US

Funding

Estrogen-mediated mechanisms of stress susceptibilityR01MH113892 · NIMH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI WOOD, SUSAN KATHLEEN · 2018 to 2022
$2.0M
Immune basis for hippocampal cholinerginc deficits in pyridostigmine-treated ratsI01BX002664 · VA · VETERANS HEALTH ADMINISTRATION · PI LAWRENCE P REAGAN · 2015 to 2026
–
BLRD VA I01 BX002664NIMH NIH HHS R01 MH113892
6 · The paper itself

Abstract

Chronic or repeated social stress exposure often precipitates the onset of depression and cardiovascular disease (CVD). Despite a clear clinical association between CVD and depression, the pathophysiology underlying these comorbid conditions is unclear. Chronic exposure to social stress can lead to immune system dysregulation, mitochondrial dysfunction, and vagal withdrawal. Further, regular physical exercise is well-known to exert cardioprotective effects, and accumulating evidence demonstrates the antidepressant effect of exercise. This review explores the contribution of inflammation, mitochondrial dysfunction, and vagal withdrawal to stress-induced depression and CVD. Evidence for therapeutic benefits of exercise, anti-inflammatory therapies, and vagus nerve stimulation are also reviewed. Benefits of targeted therapeutics of mitochondrial agents, anti-inflammatory therapies, and vagus nerve stimulation are discussed. Importantly, the ability of exercise to impact each of these factors is also reviewed. The current findings described here implicate a new direction for research, targeting the shared mechanisms underlying comorbid depression-CVD. This will guide the development of novel therapeutic strategies for the prevention and treatment of these stress-related pathologies, particularly within treatment-resistant populations.

Indexed as

Cardiovascular DiseasesVagus Nerve StimulationDepressionHumansInflammationVagus NerveCytokineDepressionExerciseInflammationMitochondriaVagus

Identifiers

PMID32598982
PMCPMC7423695
OpenAlexW3037100896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.